(1) A versus B: = 0.36, MD, −0.26 [−0.83, 0.30] A versus C: = 0.001, MD, −0.98 [−1.58, −0.38] B versus C: = 0.004, MD, −0.85 [−1.44, −0.27] (2) A versus B: = 0.92 MD, 0.03 [−0.53, 0.59] A versus C: = 0.02, MD, −0.68 [−1.27, −0.10] B versus C: = 0.008, MD, −0.80 [−1.38, −0.21] (3) A versus B: = 0.39, MD, −0.25 [−0.81, 0.31] A versus C: = 0.003, MD, −0.91 [−1.51, −0.32] B versus C: = 0.008, MD, −0.79 [−1.37, −0.21] (4) A versus B: = 0.98, MD, −0.01 [−0.57, 0.55] A versus C: = 0.03, MD, −0.64 [−1.22, −0.06] B versus C: = 0.03, MD, −0.64 [−1.22, −0.07]
The AT group had significantly better improvements in PTSD symptoms than the WLC group. But, there was no statistically significant difference between the AT group and the CBT group.
(1) A versus D: = 0.43, MD, −0.13 [−0.47, 0.20] B versus D: = 0.88, MD, −0.03 [−0.36, 0.31] C versus D: = 0.55, MD, −0.10 [−0.44, 0.23] (2) A versus D: = 0.14, MD, −0.25 [−0.59, 0.08] B versus D: = 0.34, MD, −0.16 [−0.50, 0.17] C versus D: = 0.23, MD, −0.21 [−0.54, 0.13] (3) A versus D: = 0.34, MD, −0.16 [−0.50, 0.17] B versus D: = 0.64, MD, −0.08 [−0.41, 0.25] C versus D: = 0.54, MD, 0.11 [−0.23, 0.44]
The therapeutic effect of EA was not better than that of oral SSRI.
(1) A versus B: < 0.00001, MD, −1.77 [−2.26, −1.29] (2) A versus B: < 0.00001, MD, −1.96 [−2.46, −1.46] (3) A versus B: < 0.00001, MD, −1.53 [−2.00, −1.07]
EA plus moxa was more effective than oral SSRI therapy.